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Objective: The purposes of this study were to determine whether autogenous arterial
grafts to distal pedal arteries improve the patency of grafts and limb salvage in patients
with end-stage renal disease and nonhealing ischemic wounds and to better define the
indications for autogenous arterial grafts.
Design: A review of consecutive patients with end-stage renal disease undergoing auto-
genous arterial grafts from 1994 through 1999 was carried out. The setting was a uni-
versity hospital. All 11 patients with end-stage renal disease and nonhealing, ischemic
wounds (stage IV SVS-ISCVS classification) undergoing autogenous arterial grafting
from 1994 to 1999 were evaluated. Noninvasive studies confirmed inadequate perfu-
sion pressures in all patients. Pre-bypass arteriography identified no major arteries
patent at the level of the malleolus, with reconstitution of only a distal or branch pedal
or plantar vessel less than 1 mm in diameter. Five patients with patent tibial vessels to
just above the ankle underwent bypass surgery with autogenous arterial grafts alone.
Six patients also had proximal occlusive disease that required grafts longer than the
autogenous arterial grafts; in each of these six patients, an autogenous vein graft prox-
imal to the autogenous arterial graft was placed through use of a composite technique.
Inflow was from the common femoral artery in one patient, the popliteal artery in five
patients, and a tibial artery in five patients. Outflow was to the medial plantar artery
in five patients, the distal dorsalis pedis artery in three patients, the lateral plantar
artery in two patients, and the superficial arch in one patient. The conduit was the sub-
scapular artery in four patients, the deep inferior epigastric artery in four patients, the
superficial inferior epigastric artery in two patients, and the radial artery in one patient.
The main outcome measures were assisted primary graft patency and functional limb
salvage rate.
Results: Follow-up ranged from 6 to 63 months (mean, 20 months); graft patency was
determined by means of duplex scanning. All 11 patients are alive, and nine grafts are
patent, including three after revision for graft stenosis. Assisted primary patency was
82% at 3 years. All nine patients with patent grafts remained ambulatory and had healed
wounds or limited forefoot amputations.
Conclusion: Autogenous arterial grafts were effective in treating limb-threatening
ischemia in patients with end-stage renal disease and inframalleolar arterial insufficien-
cy. Graft patency and limb salvage rates were higher than those reported for autogenous
vein graft in these patients. Autogenous arterial grafting may therefore prove to be an
effective alternative to autogenous vein grafting in selected patients. (J Vasc Surg
2000;32:13-22.)
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Autogenous vein grafts (AVGs) to inframalleolar
arteries are associated with excellent patency and
limb salvage in most patients. However, results have
been significantly less gratifying in patients with end-
stage renal disease (ESRD).1,2 In these patients,
arterial occlusive disease distal to the malleolus and
affecting arteries within the foot may result in inad-
equate perfusion to areas of ischemia or infection.2
Technical limitations to more distal revascularization
include (1) size disparity when the outflow artery’s
diameter is less than 1 mm and (2) limited runoff,
resulting in very low graft velocities and AVG
thrombosis.
In an attempt to provide sufficient revasculariza-
tion and obtain successful wound healing in patients
with ESRD, we have used autogenous arterial grafts
(AAGs) to distal pedal or plantar arteries placed
under microscopic visualization. This technique has
been reserved for patients not amenable to tradi-
tional AVG and for patients undergoing AVG to
more proximal sites in whom limited outflow has
jeopardized graft patency, thereby necessitating revi-
sion to more distal sites within the foot to maintain
bypass graft function. The current study was under-
taken to review our experience with this approach
and to better define the effectiveness and limitations
of the technique.
METHODS AND MATERIALS
Patient evaluation. Clinical evaluations, nonin-
vasive study findings, and arteriograms of patients
with ESRD undergoing AAG from 1994 through
1999 were reviewed. Patients were treated on a
teaching vascular surgical service in a university hos-
pital, all operations being performed by a combined
plastic surgical and vascular surgical team. ESRD was
defined as a creatinine level higher than 6.0, the
requirement of chronic hemodialysis, or prior renal
transplantation. Data that were collected pertain to
patient demographics, risk factors, noninvasive
hemodynamics, details of the operative procedure,
and clinical course. Patency of tibial, pedal, and
plantar arteries was evaluated on the basis of preop-
erative arteriograms and intraoperative findings.
Initial patient evaluation included a clinical
examination, plain radiographs of the foot, measure-
ment of ankle-brachial indices (ABIs) and toe pres-
sures, pulse volume recordings of the affected
extremity, and Doppler waveforms at the ankle.
Wounds underwent debridement of infected or non-
viable tissue, but major amputations were deferred
until review of the vascular studies provided evi-
dence of the need for revascularization. Patients with
more extensive infection or osteomyelitis were usu-
ally hospitalized to allow for the administration of
intravenous antibiotics and appropriate wound care.
Wounds were usually treated with saline dressings
two or three times a day in conjunction with appro-
priate antibiotic coverage.
Patients underwent digital subtraction arteriog-
raphy, magnetic resonance angiography, or cut film
arteriography; the injection catheter was frequently
positioned below the knee to allow for maximum
opacification of distal vessels. Magnetic resonance
angiography was used in patients with elevated crea-
tinine who were not undergoing hemodialysis in an
attempt to preserve renal function. Vasodilators and
magnification were used when necessary. Papaverine
and nitroglycerine were used to minimize vasospasm
and improve visualization of smaller arteries.
The decision to proceed with revascularization
was made by the attending vascular surgeon.
Chronic nonambulatory patients and those with
nonsalvageable extremities were not considered for
bypass procedures. During the same period, most of
the patients were treated with primary amputation;
the exact number is unknown, inasmuch as many
were never referred for vascular surgical evaluation.
However, patients were not denied possible revascu-
larization because of medical comorbidities, lack of
autogenous vein, or occlusive lesions not amenable
to traditional AVG. The presence of diabetes melli-
tus or renal insufficiency did not influence the deci-
sion to proceed with reconstruction.
Patients with occlusive lesions proximal to the
malleolus and reconstitution of a tibial or juxta-
malleolar artery underwent traditional bypass graft-
ing with autogenous vein alone and were not includ-
ed in this review. Patients with lesions distal to the
malleolus and reconstitution of the distal dorsalis
pedis artery or a plantar artery less than 1 mm in
diameter were treated with AAG. Combined proxi-
mal and distal lesions were treated with composite
grafts, autogenous vein being used proximally.
Operative technique. For patients undergoing
composite grafts, the AAG was connected to the
AVG through use of a functional end-to-end anasto-
mosis. The distal anastomosis was usually construct-
ed end to side to the outflow artery through use of
interrupted 9-0 or 10-0 monofilament suture under
microscopic visualization. The end-to-side configu-
ration was used to preserve retrograde perfusion,
because many of these patients had extremely limit-
ed or diseased antegrade runoff. Some patients with-
out patent retrograde outflow underwent end-to-
end distal anastomosis. In each of four patients, a
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side branch of the arterial graft was occasionally pre-
served to allow for a distal anastomosis to two sepa-
rate pedal arteries. Completion duplex scans were
obtained either in the operating room or early in the
postoperative period to insure technical adequacy.
Grafts were usually placed subcutaneously to allow
for easier surveillance and repair.
The selection of the arterial graft was made pre-
operatively on the basis of the site of previously har-
vested conduits, the length, size, and configuration
of the vein and artery required, and the possibility of
inducing tissue ischemia at the harvest site.
Noninvasive studies and arteriograms were not rou-
tinely obtained to determine the patency, size, loca-
tion, or suitability of the arterial graft. If the select-
ed artery was found at exploration to be extensively
diseased or otherwise unsuitable, other arterial grafts
were explored. During the course of the study, one
patient was found on the basis of operative evalua-
tion to have no adequate arterial conduits; this
patient could not undergo revascularization and has
not been included in the present series. This con-
firms that the patient population was a highly select-
ed group. In addition, because many of the patients
underwent primary amputation, our results do not
reflect all patients with inframalleolar disease.
The deep inferior epigastric artery (DIEA) was
used preferentially for straight grafts because of its
relatively constant size and location, which allowed
for easy accessibility. The superficial inferior epigas-
tric artery was used occasionally, but its use was lim-
ited because it was frequently too small or difficult
to identify. The subscapular artery, including the
thoracodorsal and serratus branches, was used for
bifurcated grafts, the radial artery being reserved for
patients without other suitable conduits or requiring
AAGs longer than 15 cm. This vessel is also larger
than many of the other vessels and was often
reserved at our institution for coronary revascular-
ization in selected patients.
Management was similar for patients treated with
AAG and other patients at our institution undergo-
ing traditional bypass grafting with autogenous vein.
Patients received aspirin preoperatively and were
maintained on aspirin postoperatively. Heparin
reversal with protamine was at the discretion of the
operating surgeon. Patients with hypercoagulable
states or failed previous reconstructions were main-
tained on Coumadin. Dextran was not used.
Follow-up. Follow-up included clinical exami-
nations, ankle-brachial indices or toe pressures with
waveforms, and regular duplex graft surveillance.
Scans were obtained postoperatively at 1 month and
3 months, then every 3 months for the first 2 years,
and then every 6 months thereafter. For patients
undergoing composite AVG and AAG, revision of
the AVG was performed for a velocity ratio in the
stenotic segment that was elevated in comparison
with that in the proximal graft. Because no formal
criteria have been established for evaluation or revi-
sion of AAG, repair was performed only when there
was evidence of stenosis in conjunction with distal
hemodynamic deterioration. Arteriograms were not
routinely obtained before AVG revision but were
obtained if repair of an AAG was considered.
Data analysis. Given the small number of
patients, no attempt was made to statistically analyze
the demographic variables, cardiovascular risk fac-
tors, or details of the operative procedure. Each limb
was independently evaluated during the analysis.
Results were analyzed and reported in accordance
with the reporting standards of the Society for
Vascular Surgery and the North American Chapter
of the International Society for Cardiovascular
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Life table data for 11 patients with renal failure undergoing autogenous arterial bypass grafting
No. of patients Patency
Interval (mo) At risk Failed Withdrawn Interval Cumulative
0-1 11 2 0 0.82 1.00
1-3 9 0 0 1.00 0.82
4-6 9 0 1 1.00 0.82
7-9 8 0 2 1.00 0.82
10-12 6 0 0 1.00 0.82
13-18 6 0 3 1.00 0.82
19-24 3 0 0 1.00 0.82
25-30 3 0 2 1.00 0.82
31-36 1 0 0 1.00 0.82
37-42 1 0 0 1.00 0.82
43-48 1 0 0 1.00 0.82
49-60 1 0 0 1.00 0.82
61-72 1 0 1 1.00 0.82
Surgery.3 Assisted primary graft patency and foot
salvage rates were determined through use of the life
table method. Assisted primary patency was defined
as continuous graft patency despite the need for
graft revision. Foot salvage was defined as mainte-
nance of nonassisted ambulation, with amputation,
if required, limited to the forefoot.
RESULTS
Patient population. From 1994 through 1999,
13 patients underwent AAG at a university hospital
for treatment of an ischemic nonhealing wound or
gangrene. This represents a consecutive series of
patients undergoing the procedure. Eleven of these
patients had ESRD; 6 were on hemodialysis, 3 had
creatinine levels greater than 6.0, and 2 had func-
tioning renal transplants. Five of the 11 patients
underwent AAG alone; six had composite AVG and
AAG.
The study group consisted of nine men and two
women (mean age, 51 years), and all patients had
tissue loss or gangrene from atherosclerotic periph-
eral vascular disease. Associated cardiovascular risk
factors included diabetes in six patients (54%),
hypertension in 10 (91%), current or past cigarette
use in two (18%), and cardiac disease in two (18%).
All patients with nonhealing wounds had failed non-
operative therapy, frequently before vascular surgical
evaluation. One patient had undergone a previous
bypass graft procedure on the affected extremity,
and three patients had undergone contralateral limb
bypass graft procedures. One patient had a function-
ing proximal arterial reconstruction.
The preoperative ABIs ranged from 0.00 to 0.54
(mean, 0.26). Patients with clearly artificially elevat-
ed ABIs were excluded from the ABI analysis. For
the six patients requiring composite grafts, the mean
ABI was 0.22, reflecting extensive femoropopliteal
or tibial disease in addition to the occlusive lesions
within the foot. For the five patients undergoing
AAG alone, the mean ABI was 0.31. The mean toe
pressure for all patients was 0.13 mm Hg (range,
0.00-0.26 mm Hg). Seven patients had lesions lim-
ited to one or more toes, three patients had wounds
on the plantar or dorsal forefoot overlying the
metatarsal bone, and one patient had a nonhealing
wound in the midfoot.
Procedure. In all patients, the indication for the
AAG was a distal outflow artery less than 1 mm in
diameter. Vessel size was determined by calibration
with fine dilators through an open arteriotomy dur-
ing the operative procedure. In nine patients, this
was performed as the initial procedure. Two patients
initially underwent AVG to a tibial or pedal vessel
but were found on postoperative duplex scanning to
have impaired graft flow with a distal graft velocity
less than 9 cm/sec. Each of these patients had
impending thrombosis because of minimal outflow,
with no patent arteries proximal to the midfoot that
were adequate for an extension jump graft. An AAG
was constructed to form a composite graft from the
AVG to the new outflow vessel to preserve graft
function and provide more distal perfusion. Flow
velocity after revision improved to 27 and 34
cm/sec in these two patients.
Of the six patients undergoing composite grafts,
inflow was from the common femoral artery in one
and the popliteal artery in five. All five patients treat-
ed with AAG alone had the proximal anastomosis
from a tibial or peroneal artery originating just
above the medial malleolus. Outflow was to the
medial plantar artery in five patients, the distal dor-
salis pedis artery in three patients, the lateral plantar
artery in two patients, and the superficial arch in one
patient. The conduit was the DIEA in four patients,
the subscapular artery in four patients, the superfi-
cial inferior epigastric artery in two patients, and the
radial artery in one patient. One patient had a lymph
leak at the subscapular artery harvest site; this even-
tually resolved without sequelae. There were no
other major complications related to the arterial har-
vest. Two operating teams worked simultaneously
during the procedures to reduce operative time and
the duration of distal ischemia.
Outcome. An AAG was successfully placed in
each of the 11 patients, technical adequacy being
confirmed by completion duplex scanning.
Complete follow-up was obtained on each patient
and ranged from 6 to 63 months (mean, 20
months). All patients are currently alive, and nine
grafts are patent, three having undergone subse-
quent revision for a duplex scan–identified stenosis.
Through life table analysis, the assisted primary
patency rate was found to be 82% at 2 years (Table).
The revisions were performed 1 week, 12 months,
and 22 months after the initial bypass graft; one was
located in the body of the AVG part of a composite
graft, one was at both the proximal and distal anas-
tomoses of a composite graft, and one was a distal
extension graft from the AAG just proximal to its
anastomosis with the medial plantar artery over to
the dorsalis pedis artery.
Two grafts occluded within the first postopera-
tive week, both presumably from insufficient runoff.
One of these occlusions was a bypass graft from the
distal anterior tibial artery to the distal dorsalis pedis
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artery; the subscapular artery had been used. Only
one small distal branch was patent, extending from
the outflow artery; when the graft occluded, no
attempt was made at revision. The other occlusion
involved a composite graft from the below-knee
popliteal artery to the medial plantar artery; com-
posite reversed saphenous vein and DIEA were used.
The AVG was initially performed to the distal poste-
rior tibial artery, but graft velocities were less than 7
cm/sec and the bypass graft was thought to be in
jeopardy of occluding. The AAG extension graft was
placed in an attempt to improve outflow, but runoff
was severely limited, velocity in the AVG continued
to be less than 10 cm/sec, and the composite graft
thrombosed. Both patients with graft occlusion
required below-knee amputation.
All nine patients with patent grafts had healed
open wounds or limited forefoot amputations.
Through life table analysis, functional limb salvage
was found to be 82% at 3 years. Four patients had
healed digital amputations, three had healed open
wounds, and two patients had healed transmetatarsal
amputations. Although multiple foot procedures
were occasionally required, healing in all patients
was accomplished within 12 weeks of bypass graft
construction.
After successful bypass grafting, the mean ABI
improved from 0.26 to 0.65 and the mean toe pres-
sure from 0.13 to 0.37 mm Hg (range, 0.26-0.44
mm Hg). Velocities within the AAG ranged from
166 to 313 cm/sec (mean, 266 cm/sec).
DISCUSSION
The reported patency and limb salvage rates
from inframalleolar arterial bypass grafting with vein
have continually improved over the past several
years, with several centers now reporting better than
70% to 80% success at 5 years. However, patency
rates in patients with ESRD continue to be signifi-
cantly lower than rates in patients with normal renal
function.1,2,4-12 Harrington et al,12 reporting on 56
grafts in 39 patients with ESRD over a 10-year peri-
od, noted a primary patency of 68% rate at 2 years,
although 25 of the grafts were constructed of poly-
tetrafluoroethylene. In a recent study of pedal bypass
grafts in 34 patients with renal failure, Leers et al4
found a 62% patency rate at 1 year. Johnson et al2
reported a 68% primary graft patency rate at 2 years,
significantly lower than the rate that they reported
for patients without ESRD. Whittemore et al5
reported a 77% cumulative secondary patency rate at
5 years, although many of their patients had renal
insufficiency (defined as a serum creatinine level
higher than 2.0 mg/dL) and not ESRD and no
patient on dialysis survived beyond 3 years. Baele et
al,6 reviewing a 15-year experience with 44 patients
on hemodialysis, found a secondary patency rate of
66% at 2 years and noted that the 2-year patient sur-
vival rate was only 52%.
Such results undoubtedly reflect a variety of fac-
tors that are unique to these patients, including the
following: limited distal runoff; extensive microvas-
cular disease, which further compromises outflow;
potentially calcified or lesser-quality venous con-
duits; extensively calcified distal vessels, which
increase the technical complexity of the procedure;
and an increased rate of progression of further arte-
rial occlusive disease.1,6,8
In addition, whereas limb salvage rates for
patients without ESRD continue to exceed bypass
patency rates and successful reconstruction is usual-
ly associated with foot preservation, patients with
ESRD frequently require below-knee amputations
for persistent ischemia despite patent grafts. Limb
salvage rates continue to lag behind bypass graft
patency rates in most reports.2,4,6 Baele et al6
reported a 52% limb salvage rate at 2 years despite a
secondary graft patency rate of 66%, and Johnson et
al2 found a 1-year limb salvage rate of 51% in
patients admitted with gangrene. Leers et al4 report-
ed a 56% limb salvage rate at 12 months (graft
patency rate: 62%); 7 of 16 amputations were per-
formed despite patency of the bypass graft.
Although part of this difference between limb
salvage and graft patency may reflect microvascular
disease, another cause is the inability to control
infection or heal wounds because of the anemia,
malnutrition, impaired immune function, and limit-
ed granulation tissue formation that are associated
with ESRD.1,2,6,13 Additional reasons for failure of
limb salvage include the inability to obtain adequate
perfusion to the distal foot despite a patent proximal
bypass,2 the inability to construct a graft when
occlusive disease is exclusively inframalleolar and the
vessels are less than 1 mm in diameter, and the
inability to maintain a functioning bypass graft
because of limited outflow with very slow graft
velocity.
The role of diabetes is difficult to determine.
Fifty-one percent of our patients had diabetes, which
is lower than the percentages in the reports of
Chang et al9 (67%), Harrington et al12 (56%),
Sanchez et al7 (70%), and Baele et al6 (75%). The
small numbers of patients in our study and some of
the others make any conclusions difficult and subject
to a type II statistical error.
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In an attempt to improve graft patency and limb
salvage in these patients, we began using AAGs to
distal pedal and plantar arteries. The approach was
developed because of several potential advantages.
This sort of graft brings a higher perfusion pressure
closer to an area of ischemia and offers the opportu-
nity to bypass to a smaller, more distal artery with
minimal size discrepancy. The flow velocity is likely
to be significantly higher than the velocity in most
venous conduits because of the smaller caliber of the
arterial graft. The procedures are performed under
microscopic visualization, which potentially
improves technical adequacy, and the conduits are
less likely to develop atherosclerotic, myointimal, or
calcific changes in comparison with AVG.14,15
The choice of conduit is based on both patient
and technical factors. Almost all of the arterial grafts
are less than 15 cm in length, so proximal compos-
ite grafts are required for patients with both
femoropopliteal or tibial and pedal occlusive disease.
The subscapular artery, because of its natural bifur-
cation, has been used in patients with two patent
outflow vessels. The effect of using a side branch
could not be reliably determined because it was used
in only 4 patients. The DIEA has been used prefer-
entially for straight grafts because of its relatively
constant location, easy accessibility, good length,
and maintenance of good quality despite otherwise
extensive atherosclerotic disease. Use of the larger
radial artery has been associated with lower patency
in coronary revascularization.16-18 However, the
lower patency of radial artery grafts in comparison
with other AAGs may also reflect its use in more dis-
advantageous situations.18 We have therefore
reserved its use for patients without other available
arterial grafts or requiring arterial conduits longer
than 15 cm.
Preoperative assessment of the AAG with duplex
scanning may be helpful in identifying the best AAG;
however, we have not used it in this setting, because
(1) these vessels are rarely diseased and (2) size and
length are more precisely evaluated by direct obser-
vation. Duplex scanning has been useful in assessing
larger internal mammary artery grafts before coro-
nary artery bypass grafting18,19 and is now often
used before cardiac procedures.
Procedures have been performed by joint oper-
ating teams of plastic and vascular surgeons, with
vascular surgeons harvesting the AVGs and perform-
ing the proximal anastomoses. Tourniquets were
used by the vascular surgeons during construction of
the proximal anastomoses in patients requiring com-
posite venous and arterial grafts; this eliminated the
need for vessel clamps or intraluminal arterial
occluders. The plastic surgeons involved in these
reconstructions have had extensive experience with
microvascular anastomoses and have therefore har-
vested the AAGs and performed the distal anasto-
moses, microvascular vessel clamps being used for
temporary arterial occlusion. Intraluminal vessel
occluders were used for persistent bleeding.
Interrupted sutures of 9-0 or 10-0 monofilament
nylon, standard for microvascular anastomoses of
vessels of this size, were used in an attempt to reduce
the incidence of stenosis at the distal anastomosis.
Papaverine and verapamil have been found useful,
both in our study and those of others, to reduce
arterial spasm during harvesting of the AAG.15
The end-to-side configuration was used distally
to maximize runoff, with two separate distal anasto-
moses occasionally being performed. Although par-
allel distal anastomoses have not improved the
patency of AVG, we hoped that the parallel con-
struction of 2 distinct distal anastomoses might
improve patency of the AAG by increasing flow
through the main body of the bypass graft inasmuch
as the arterial outflow in all patients was severely lim-
ited. The small caliber of the outflow arteries made
it difficult to predict the expected graft patency or
determine which outflow vessel was likely to be able
to support the bypass graft. In one patient, one of
the distal anastomoses, as well as the body of the
AAG, remained patent despite loss of the second
limb of the graft.
Experience with AAGs in the peripheral circula-
tion has been limited, and information on hemody-
namic parameters and expected bypass patency is
unavailable. This may reflect (1) difficulties in har-
vesting the arteries, which are often less than 1 mm
in diameter; (2) the technical requirements of a dis-
tal microvascular anastomosis; (3) minimal data on
the durability of the bypass graft; and (4) the pre-
sumption that direct perfusion to the distal foot is
unlikely to significantly improve limb salvage rates
over those associated with more proximally placed
grafts.
Patency of some arterial grafts, primarily internal
thoracic grafts, in the coronary circulation has been
found to be higher than patency of saphenous vein
grafts.18,20-22 Even though internal mammary artery
grafts are smaller in diameter than autogenous
saphenous vein grafts, they have remained patent,
with flow rates comparable to those of femoral tibial
or femoral pedal bypass grafts.15
Follow-up duplex scans in our study showed that
velocities in the AAG averaged 266 cm/sec, signifi-
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cantly higher than the velocities seen in the venous
component of the composite grafts and in infra-
malleolar grafts composed of autogenous vein.
Velocities in the outflow arteries have also been
greater than 250 cm/sec, reflecting smaller vessel
diameter. However, these velocities suggest that the
tissues and microcirculation are able to provide suf-
ficient outflow to support this volume of flow.
Our experience suggests that revision of these
grafts should be performed not according to tradi-
tional velocity criteria but rather on the basis of the
presence of stenosis associated with evidence of
hemodynamic deterioration. Although surveillance
of an AVG has been associated with improved paten-
cy, whether surveillance of an AAG is beneficial is
unknown. In addition, patch angioplasty or revision
of an anastomosis is technically almost impossible,
which mandates creation of a new anastomosis, fre-
quently to a different outflow vessel.
Our initial results—an 82% assisted primary
patency rate at 3 years—are better than the results
usually reported for patients with ESRD requiring
inframalleolar arterial reconstruction with autoge-
nous veins. In part, this reflects careful patient selec-
tion, because patients who had nonsalvageable
extremities or were unable to tolerate the procedure
underwent primary amputation. Even more encour-
aging, however, are the 82% limb salvage rate and
the ability of every patient with a patent bypass to
maintain a functional limb. This may reflect careful
patient selection, yet we did not exclude any patient
because of the nature of the infection, location of
the wound, length of previous nonhealing, or tech-
nical requirements for the operation. However, no
patient in our study had a nonhealing heel wound or
extensive midfoot gangrene or infection. Further
follow-up will be necessary to confirm the durable
nature of these results at our institution. In addition,
application of this technique at other institutions
with combined microvascular and vascular surgical
teams will be required to confirm the value of the
approach.
CONCLUSION
The frequent failure of traditional revasculariza-
tion in patients with nonhealing wounds, arterial
insufficiency, and ESRD has prompted many authors
to recommend primary amputation as the initial
treatment modality in selected circumstances.2,3,5,7
However, our approach, by providing direct perfu-
sion to the distal foot through use of conduits that
might remain patent in situations in which autoge-
nous vein grafts could fail, offers the potential to
improve functional limb salvage in patients with
ESRD. The limited number of patients whom we
have treated with AAG, combined with nonhealing
wounds that were limited to the forefoot or midfoot
in all patients, does not allow us currently to con-
clude that AAG will salvage limbs that other reports
have determined are best treated with BKA. Again,
it should be emphasized that this represented a
selected group of patients, all of whom had salvage-
able extremities and were able to tolerate the proce-
dure. The results are promising enough that this
approach will continue to be offered to patients with
ESRD, foot ischemia, and distal arterial disease.
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DISCUSSION
Dr Giacomo DeLaria (San Diego, Calif). I very much
enjoyed Dr Rockwell’s presentation and appreciate the
early receipt of his manuscript. He and his colleagues in
vascular surgery have taken on a particularly difficult
patient group: end-stage renal disease patients with gan-
grene and arterial obstructive disease distal to the malleo-
lus. They treated 11 patients, and nine healed their ulcers
and were spared below-knee amputations. Success in this
endeavor has been ascribed to improved and more 
successful revascularization using autologous arterial 
conduits.
Arterial grafts are infrequently used in peripheral vas-
cular surgery but have become the preferred conduit in
coronary bypass operations. Simulated by the durability of
the internal thoracic artery cardiac surgeons have explored
multiple other grafts including the ulnar and inferior epi-
gastric, gastroepiploic, and radial arteries. Today the
majority of surgeons choose the internal thoracic and radi-
al arteries both for ease of harvest and handling. Arterial
grafts are thought to be more successful for several rea-
sons: size match, preserved endothelial function, and
accustomed hemodynamics. However, compared with
veins the prominent muscle layer in arterial grafts makes
them more prone to spasm.
Early on the use of radial and ulnar arterial grafts was
abandoned by coronary surgeons because of an angio-
graphically documented incidence of early occlusion.
Later, study of these same patients in one large French
series documented previously closed grafts to be open.
These premature closures were ascribed to competitive
flow hemodynamics or spasm. It was proposed that the
continued endothelial function in these arterial grafts
allow previously closed grafts to subsequently reopen.
Now because of better selection of distal targets with high-
grade proximal stenosis, preventative pharmacological
treatment to prevent spasm before, during, and after
surgery, and improved technique, the patency rates in
these grafts now approximate those associated with the
internal thoracic artery.
In this report the arterial grafts most often used were
the inferior epigastric and subscapular arteries. These vessels
are 1 mm in diameter and were selected to match the size
of the distal targets. Results were uniformly good. Assisted
patency was greater than 80%. Successful patients walked
without assistance. I believe the results herein reported are
truly excellent and better than ever previously described.   
I have three questions for the author.
1. Is the real benefit of an arterial graft in this circum-
stance the conduit or its caliber? In other words, 
would superficial 1- to 2-mm vein grafts from the 
forearm function equally well?
2. No special effort during operation or after was taken 
to prevent arterial spasm. This has been demon-
strated to be very important when using radial and 
epigastric arteries in the coronary circulation. Would
results have been improved by the use of intraopera-
tive and postoperative calcium channel blockers or
nitrates?
3. There was no mention on the report of the degree
of calcification in these small distal vessels. Was any
degree of calcification a contraindication to this
procedure? Once again I commend the authors on 
their excellent results and thank the society for the 
opportunity of discussing this paper.
Dr W. Bradford Rockwell. I appreciate your comments
very much. As to the question whether the results are
mainly due to the arterial conduit or to the caliber of the
vessel, there is no possible way to definitely determine that.
I suspect that it is both. Certainly sewing an artery to an
artery under a microscope is considerably easier than
sewing a vein to the artery. The chance of placing a stitch
in the back wall is significantly decreased.
I think also the caliber makes a difference, and because
of the normal anatomic taper of an artery, we can take the
segment of artery that most appropriately matches the dis-
tal target vessel. Sometimes we will take the larger part of
the artery or sometimes the more distal, but I think that
appropriate size match is important.
With the artery, we can dissect out very distally and
get a small vessel if we need to. It is our observation that
an artery is easier to sew than a small-caliber vein. We have
not tried a reverse vein, even a small-caliber reverse vein
on these small vessels, but getting the appropriate size
match would be more difficult with a vein.
In response to the second question regarding drugs to
prevent spasm, we have not used medication for this indica-
tion. We have used heparin and subsequently Coumadin in
some salvage situations. The literature regarding micro-
surgery, not in patients with vascular disease but replanta-
tions and free tissue transfers, does not support the use of
any other drugs. The only factor that has been shown to
make a difference in free tissue transfers is the number of
anastomoses.
If the vessels require lengthening with a vein graft, there
is an adverse effect on the survival of the flap. If we take
those same data and apply them to this situation, then cal-
cium channel blockers or other pharmacologic aids would
not help. In this study we do not have an answer to that.
We did use aspirin postoperatively in all the patients,
and for standard microsurgical procedures aspirin has been
shown to be beneficial. No other pharmacologic aids have
any proven benefit.
Calcifications in the distal vessel were not contraindi-
cations to these procedures. We had preoperative arteri-
ograms in all the patients, and the only criteria we had for
operating on these patients were a salvageable extremity
and a patent target vessel on the foot, although that target
vessel in most of the patients often did not have a good
runoff on the arteriogram. A segment of the medial plan-
tar artery was most frequently suitable for distal anasto-
moses.
A number of these vessels were calcified, but the
extent of calcification was not definitively known until the
time of surgery. We were still able to complete the proce-
dures. Even though some of the distal vessels looked
severely diseased in the operating room, the patency
results were fairly good. I think calcification should not be
a contraindication to the procedure in otherwise suitable
patients.
Dr Ron Stoney. That was a very nice paper and a very
interesting innovative way to use arteries to restore or
repair arterial defects. Jack Wylie introduced this in 1964,
and at UCSF we have used this over the last three decades
extensively, not in this particular location, but the smaller
branches of the internal iliac artery have been used to
revascularize nearly 90 kidneys by an ex vivo method.
So we have some experience at least with the use of
these smaller flows through smaller diameter arteries, and
I would predict that the longer term results in these
patients will nearly match those that we have observed.
One thing that comes to my mind about these cases is
the benefit that you may convey to patients by putting
arterial grafts across a mobile joint. We found using the
external iliac artery for replacing popliteal or subclavian
artery lesions related to trauma and learned that move-
ment across these joints produced normal mobility of
these arterial grafts. This may be a benefit that you will
convey to your patients using this arterial autograft tech-
nique. It was a very nice paper. Thank you.
Dr Rockwell. The artery would have more extensibili-
ty, and placing it across a joint may well have an added
benefit.
Dr Greg Moneta. The thing I found most impressive in
your presentation was the extent of healing in your
patients. All of us have the experience of renal failure
patients despite having patent grafts not being able to heal
their lesions. The likelihood of healing has to do with the
extent of the gangrene.
What was the extent of gangrene in these patients?
How many patients did you choose not to revascularize
but rather performed primary amputation?
Dr Rockwell. The patients who underwent these distal
bypasses had gangrene usually limited to the digits. There
were some clean ulcers in the foot, but the majority of
patients had necrotic digits. There was some superficial
gangrene on the forefoot, but it did not appear to extend
deeper into the foot. A few patients underwent some local
tissue debridement preoperatively, but all wounds had no
gross infection at the time of bypass.
Dr George Andros. I think this is an interesting paper
and comes from a point of view different from what we
usually hear, namely, from the plastic surgical point of
view. I was going to ask the same question that Greg
Moneta did. In this unique group of patients limb salvage
may be less than graft patency, whereas the reverse is the
case for patients without renal failure.
I was surprised at the ankle/arm indices that measure.
You did not have a single ankle/arm index greater than
one, yet half of your patients were diabetics. You seem to
minimize the importance of calcification.
We find arterial calcification not only a major compli-
cating problem in these patients, but saphenous vein calci-
fication is a problem as well. Finding an adequate segment
of vein in end-stage renal patients is often a problem as
well as finding a soft artery to go to. In fact, the finding of
a soft spot in the pedal artery is a rarity.
Your ankle/arm indices support my suspicion that
these pedal vessels probably are not as calcified as the aver-
age end-stage diabetic that we see most often.
Approximate extrapolation from Dr Treiman’s data
from yesterday, he reported a total of 23 pedal bypasses in
the same time period as yours. Were your 11 with end-
stage renal disease included in the 23? If so, about half of
your patients that get pedal bypasses had end-stage renal
disease. This is quite different from our experience. Most
of our patients who receive pedal bypasses are diabetics,
with a small but growing percentage of end-stage renal
diabetics.
I was also impressed that most of your patients got
very distal bypasses to the lateral tarsal, medial, or lateral
plantars. In our experience, these vessels are every bit as
calcified as the other paramalleolar vessels.
The number that stuck out in my mind was “less than
1 mm” artery diameter. We rarely encounter arteries that
are less than 1 mm.
How do you measure the diameters of less than 1 mm?
Did you use a 1-mm probe, or was it measured from
the angiogram? 
Dr Rockwell. Regarding the calcification, the vast
majority of perhaps all of these patients had calcifications
in the vessels in the foot, and sewing into these vessels
with a small needle from a 9-0 or 10-0 nylon suture was
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sometimes difficult. The needle would often bend.
However, the alternative was a below-knee amputation. So
a number of these we tried for limb salvage and were for-
tunate to have reasonable results.
The vessel that we bypassed into was mainly determined
by the preoperative arteriogram. In some patients we would
dissect out the medial plantar and just follow it distally until
there was a soft segment. The arteriogram would help local-
ize the area, but then really where there was a soft spot in the
vessel would be where we would do the distal anastomosis.
The arterial conduits we used in general were pretty
good vessels, and whether in the more truncal part of the
body they are more protected from calcification is
unknown. There was one patient we hoped to bypass, but
we could not get a suitable arterial conduit and, therefore,
did not attempt the bypass. In these patients, the arterial
conduits seem to spare some calcification.
The 1-mm vessel was really the internal diameter of
the artery, not the external diameter. It was not measured
by a probe, but rather by taking just a small ruler and plac-
ing it under the microscope at the time of the anastomo-
sis. It was just an estimate based on the size of the internal
diameter and our ruler.
Dr Gerald Treiman. I appreciate the opportunity to
respond to some of the issues that have been raised. The
ankle-brachial index in some patients with severely calci-
fied vessels was falsely elevated and was not an accurate
reflection of pedal perfusion. It was not utilized for this
study. Instead, we relied on toe pressures, which we
thought were much more accurate.
In reconciling the current study with our previous
reports on pedal bypass, the 11 patients undergoing AAG
represent a small subset of the total umber of patients
undergoing pedal bypass in these institutions during this
time period. Overall, we have performed more than 40
pedal bypasses, as well as some primary amputations.
As far as the extent of the gangrene, patients with
extensive gangrene or nonsalvageable extremities were not
evaluated for possible AAG. All of the patients in this
study had limited gangrene. Some patients with nonsal-
vageable extremities underwent primary amputation, even
though AAG or pedal bypass may have seemed technical-
ly possible. Most patients are not candidates for this pro-
cedure, and it is reserved for those patients who are felt to
have limited gangrene, who have a suitable distal target,
and who have an adequate conduit.
I hope this study will provide a stimulus for other
institutions to consider this technique in the future treat-
ment of these patients.
Dr Dennis Baker. We often find extensive calcification
in radial arteries of patients with end-stage renal disease.
Did you explore any arteries that you’re not able to use for
grafts as a result of calcification?
Dr Rockwell. There was only one patient that fit that
category, and I think the hope in that patient was to use a
venous conduit. It turned out that there was no suitable
vein found at exploration in the operating room. So we
searched for a suitable artery and did not find one either.
I think the more truncal vessels that we use for free
flaps seem to have some protective effect. Although there
is some calcification in them, the deep inferior epigastric
artery and the subscapular artery, which originate in the
axilla, seem to have some protective effect, even when
there is more calcification peripherally. There is some cal-
cification there, but it does not seem to be to the extent
that we find in the peripheral arteries in the foot.
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